Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency

Biochemical and Molecular Medicine

Volumn 62, Issue 2, 1997, Pages 151-158

  Witchel, Selma F ^a   Lee, Peter A ^a   Suda Hartman, Makiko ^a   Hoffman, Eric P ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Congenital adrenal hyperplasia; Hyperandrogenism; Polycystic ovary syndrome; Premature pubarche

Indexed keywords

ADOLESCENT; ADRENARCHE; AMENORRHEA; ANDROGEN RELEASE; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; ENZYME DEFICIENCY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEGREGATION; HETEROZYGOTE; HIRSUTISM; HUMAN; HYPERANDROGENISM; MALE; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; STEROID 21 MONOOXYGENASE DEFICIENCY;

EID: 0031405108     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1997.2632     Document Type: Article

References (44)

1. Franks S. Polycystic ovary syndrome. N Engl J Med. 333:1995;853-861.
2. Nobels F, Dewailly D. Puberty and polycystic ovarian syndrome: The insulin/insulin-like growth factor I hypothesis. Fertil Steril. 58:1992;655-666.
3. Ehrmann D A, Barnes R B, Rosenfield R L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocrin Rev. 16:1995;322-353.
4. Ibañez L, Potau N, Virdis R, Zampoli M, Terzi C, Gussinyé M, Carrascosa A, Vicens-Calvert E. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: Increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 76:1993;1599-1603.
5. McDonough P G, Mahesh V B, Ellegood J O. Steroid, follicle-stimulating hormone and luteinizing hormone profiles in identical twins with polycystic ovaries. Am J Obstet Gynecol. 113:1972;1072-1076.
6. Hague W M, Adams J, Reeders S T, Peto T EA, Jacobs H S. Familial polycystic ovaries: A genetic disease? Clin Endocrinol. 29:1988;593-605.
7. Simpson J L. Elucidating the genetics of polycystic ovary syndrome. Polycystic Ovary Syndrome. 1992;Blackwell Scientific, Boston. p. 59-69.
8. Legro R S. The genetics of polycystic ovary syndrome. Am J Med. 98:1995;9S-16S.
9. Ferriman D, Purdie A W. The inheritance of polycystic ovary disease and possible relationship to premature balding. Clin Endocrinol. 1:1979;291-299.
10. Lunde O, Magnus P, Sandvik L, Hoglo S. Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest. 28:1989;23-30.
11. Carey A H, Chan K L, Short F, White D, Williamson R, Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol. 38:1993;653-659.
12. Gharani N, Waterworth D M, Batty S, White D, Gilling-Smith C, Conway G S, McCarthy M, Franks S, Williamson R. Association of the steroid synthesis geneCYP11a. Hum Molec Genet. 6:1997;397-402.
13. Waterworth D M, Bennett S T, Gharani N, McCarthy M I, Hague S, Batty S, Conway G S, White D, Todd J A, Franks S, Williamson R. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet. 349:1997;986-990.
14. Gharani N, Waterworth D M, Williamson R, Franks S. 5′ polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. J Clin Endocrinol Metab. 81:1996;4174.
15. S, F, Witchel, P, A, Lee, M, Suda-Hartman, E, P, Hoffman, 1997, No mutations identified in CYP17 gene in patients with symptoms of hyperandrogenism. Endocrine Society Annual Meeting.
16. White P C, New M I, Dupont B. Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA. 83:1986;5111-5115.
17. Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene. Proc Natl Acad Sci USA. 83:1986;2841-2845.
18. Higashi Y, Hiromasa T, Tanae A, Miki T, Nakura J, Kondo T, Ohura T, Ogawa E, Nakayama K, Fujii-Kuriyama Y. Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem. 109:1991;638-644.
19. Morel Y, Miller W L. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet. 20:1991;1-68.
20. Knorr D, Bidlingmaier F, Höller W, Kuhnle U, Meiler B, Nachman A. Is heterozygosity for the steroid 21-hydroxylase deficiency responsible for hirsutism, premature pubarche, early puberty, and precocious puberty in children? Acta Endocrin Suppl. 279:1986;284-287.
21. Azziz R, Owerbach D. Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation. Am J Obstet Gynecol. 172:1995;914-918.
22. Siegel S F, Lee P A, Rudert W A, Swinyard M, Trucco M. Phenotype/genotype correlations in 21-hydroxylase deficiency. Adolesc Pediatr Gynecol. 8:1995;9-16.
23. Siegel S F, Hoffman E P, Trucco M. Molecular diagnosis of 21-hydroxylase deficiency: Detection of four mutations on a single gel. Biochem Med Metab Biol. 51:1994;66-73.
24. Witchel S S, Lee P A, Trucco M. Who is a carrier? Detection of unsuspected mutations in 21-hydroxylase deficiency. Am J Med Genet. 61:1996;2-9.
25. Witchel S F, Nayak S, Suda-Hartman M, Lee P A. Newborn screening for 21-hydroxylase deficiency: Results of CYP21 molecular genetic analysis. J Pediatr. 131:1997;328-331.
26. Siegel S F, Finegold D N, Murray P J, Lee P A. Assessment of clinical hyperandrogenism in adolescent girls. Adolesc Pediatr Gynecol. 5:1991;13-20.
27. S, Siegel-Witchel, P, A, Lee, M, Trucco, E, P, Hoffman, 1995, Correlation of ACTH stimulated 17-hydroxyprogesterone (17-OHP) levels in heterozygotes with molecular genotype. Endocrine Society Annual Meeting.
28. S, F, Witchel, P, A, Lee, M, Suda-Hartman, M, Trucco, E, P, Hoffman, Evidence for a heterozygote advantage in congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 82, 2097, 2101.
29. Higashi Y, Tanae A, Inoue H, Hiromasa T, Fujii-Kuriyama Y. Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. Proc Natl Acad Sci USA. 85:1988;7486-7490.
30. 172356. J Biol Chem. 265:1990;3549-3552.
31. Mornet E, Crété P, Kuttenn F, Raux-Demay M-C, Boué J, White P C, Boué A. Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. Am J Hum Genet. 48:1991;79-88.
32. Owerbach D, Ballard A L, Draznin M B. Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction. J Clin Endocrinol Metab. 74:1992;553-558.
33. Miller W L. Clinical Review 54. Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 78:1994;241-246.
34. Wedell A, Thilén A, Ritzén E M, Stengler B, Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab. 78:1994;1145-1152.
35. Azziz R, Dewailly D, Owerbach D. Nonclassic adrenal hyperplasia: Current concepts. J Clin Endocrinol Metab. 78:1994;810-815.
36. V, Tardy, J, C, Carel, M, G, Forest, M, Nicolino, M, Pugeat, M, C, Raux-Demay, Y, Morel, 1996, Nonclassical forms of 21-hydroxylase deficiency revisited by molecular biology. Endocrine Society/ICE Meeting.
37. Lee P A, Gareis F J. Evidence for partial 21-hydroxylase deficiency among heterozygote carriers of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 41:1975;415-418.
38. Krensky A M, Bongiovanni A M, Marino J, Parks J, Tenore A. Identification of heterozygote carriers of congenital adrenal hyperplasia by radioimmunoassay of serum 17-OH progesterone. J Pediatr. 90:1977;930-933.
39. New M I, Lorenzen F, Lerner A J, Kohn B, Oberfield S E, Pollack M S, Dupont B, Stoner E, Levy D J, Pang S, Levine L S. Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data. J Clin Endocrinol Metab. 57:1983;320-326.
40. J, W, Honour, G, Rumsby, P, Holownia, L, Ostlere, M, HA, Rustin, 1994, High prevalence of carriers for steroid 21-hydroxylase deficiency in females with post-adolescent acne. 76th Annual Meeting of the Endocrine Society.
41. Knochenhauer E S, Cortet-Rudelli C, Cunningham R D, Conway-Meyers B A, Dewailly D, Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab. 82:1997;479-485.
42. Taylor S I, Kadowaki T, Kadowaki H, Accili D, Cama A, McKeon C. Mutations in the insulin receptor gene in insulin-resistant patients. Diabetes Care. 13:1990;257-279.
43. Almind K, Inoue G, Pedersen O, Kahn C R. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest. 97:1996;2569-2575.
44. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Odén A, Janson P O, Mattson L-A, Crona N, Lundberg P A. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long term follow up focusing on natural history and circulating hormones. Fertil Steril. 57:1992;505-513.